Christopher Richard Anzalone Insider Trading $ARWR ARROWHEAD PHARMACEUTICALS, INC.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Christopher Richard Anzalone.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Christopher Richard Anzalone. Christopher Richard Anzalone is Chief Executive Officer in ARROWHEAD PHARMACEUTICALS, INC. ($ARWR) and President and CEO in ARROWHEAD PHARMACEUTICALS, INC. ($ARWR).

Christopher Richard Anzalone in ARROWHEAD PHARMACEUTICALS, INC.

Trading Symbol: ARWR
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Christopher Richard Anzalone: Chief Executive Officer, President and CEO
Holdings: 2,544,022 shares
Current Value: $4,986,283
Latest Transaction: Jan 04 2021
$ARWR Market Capitalization: $149.83M
$ARWR Previous Close: $1.96

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Christopher Richard Anzalone in ARROWHEAD PHARMACEUTICALS, INC.

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Jan 04 2021	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Grant	A	0.00	800,000	0	3,344,022	2.5 M to 3.3 M (+31.45 %)
Jan 04 2021	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Gift	G	0.00	599	0	2,544,022	2.5 M to 2.5 M (-0.02 %)
Dec 30 2020	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Gift	G	0.00	1,126	0	2,544,621	2.5 M to 2.5 M (-0.04 %)
Dec 22 2020	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Option Exercise	M	6.15	28,274	173,885	800,033
Dec 22 2020	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Option Exercise	M	4.75	12,236	58,121	828,307
Dec 22 2020	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Buy	M	6.15	28,274	173,885	2,545,747	2.5 M to 2.5 M (+1.12 %)
Dec 22 2020	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Buy	M	4.75	12,236	58,121	2,517,473	2.5 M to 2.5 M (+0.49 %)
Dec 10 2020	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Option Exercise	M	2.01	38,676	77,739	840,543
Dec 10 2020	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Option Exercise	M	2.01	16,324	32,811	879,219
Dec 10 2020	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Sell	S	71.61	4,003	286,655	2,505,237	2.5 M to 2.5 M (-0.16 %)
Dec 10 2020	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Sell	S	70.87	5,880	416,716	2,509,240	2.5 M to 2.5 M (-0.23 %)
Dec 10 2020	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Sell	S	69.80	12,067	842,277	2,515,120	2.5 M to 2.5 M (-0.48 %)
Dec 10 2020	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Sell	S	67.27	16,726	1,125,158	2,527,187	2.5 M to 2.5 M (-0.66 %)
Dec 10 2020	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Buy	M	2.01	38,676	77,739	2,543,913	2.5 M to 2.5 M (+1.54 %)
Dec 10 2020	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Sell	S	67.97	16,324	1,109,542	2,505,237	2.5 M to 2.5 M (-0.65 %)
Dec 10 2020	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Buy	M	2.01	16,324	32,811	2,521,561	2.5 M to 2.5 M (+0.65 %)
Aug 14 2020	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Option Exercise	M	9.90	50,000	495,000	895,543
Aug 14 2020	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Sell	S	41.35	50,000	2,067,500	2,605,237	2.7 M to 2.6 M (-1.88 %)
Aug 14 2020	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Buy	M	9.90	50,000	495,000	2,655,237	2.6 M to 2.7 M (+1.92 %)
Jun 26 2020	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Sell	S	39.55	23	910	2,605,237	2.6 M to 2.6 M (0.00 %)
Jun 26 2020	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Sell	S	38.81	99,977	3,880,107	2,605,260	2.7 M to 2.6 M (-3.70 %)
Dec 27 2019	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Sell	S	63.50	83,333	5,291,646	1,805,237	1.9 M to 1.8 M (-4.41 %)
Dec 13 2019	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Sell	S	68.18	3,393	231,335	1,888,570	1.9 M to 1.9 M (-0.18 %)
Dec 13 2019	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Sell	S	67.30	25,412	1,710,228	1,891,963	1.9 M to 1.9 M (-1.33 %)
Dec 13 2019	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Sell	S	66.47	45,577	3,029,503	1,917,375	2 M to 1.9 M (-2.32 %)
Dec 13 2019	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Sell	S	65.85	8,951	589,423	1,962,952	2 M to 2 M (-0.45 %)
Dec 13 2019	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Sell	S	69.41	8,379	581,586	1,971,903	2 M to 2 M (-0.42 %)
Dec 13 2019	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Sell	S	68.51	10,343	708,599	1,980,282	2 M to 2 M (-0.52 %)
Dec 13 2019	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Sell	S	67.31	58,059	3,907,951	1,990,625	2 M to 2 M (-2.83 %)
Dec 13 2019	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Sell	S	66.82	23,219	1,551,494	2,048,684	2.1 M to 2 M (-1.12 %)
Dec 04 2019	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Sell	S	62.00	8,022	497,364	2,071,903	2.1 M to 2.1 M (-0.39 %)
Dec 04 2019	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Sell	S	60.73	4,011	243,588	2,079,925	2.1 M to 2.1 M (-0.19 %)
Dec 04 2019	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Sell	S	72.95	3,656	266,705	2,083,936	2.1 M to 2.1 M (-0.18 %)
Dec 04 2019	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Sell	S	72.13	3,800	274,094	2,087,592	2.1 M to 2.1 M (-0.18 %)
Dec 04 2019	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Sell	S	70.72	2,448	173,123	2,091,392	2.1 M to 2.1 M (-0.12 %)
Dec 04 2019	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Sell	S	69.50	6,617	459,882	2,093,840	2.1 M to 2.1 M (-0.32 %)
Dec 04 2019	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Sell	S	68.50	8,510	582,935	2,100,457	2.1 M to 2.1 M (-0.40 %)
Dec 04 2019	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Sell	S	67.63	7,193	486,463	2,108,967	2.1 M to 2.1 M (-0.34 %)
Dec 04 2019	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Sell	S	66.58	5,743	382,369	2,116,160	2.1 M to 2.1 M (-0.27 %)
Oct 11 2019	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Option Exercise	M	5.20	56,325	292,890	945,543
Oct 11 2019	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Sell	S	31.83	56,325	1,792,825	2,121,903	2.2 M to 2.1 M (-2.59 %)
Oct 11 2019	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Buy	M	5.20	56,325	292,890	2,178,228	2.1 M to 2.2 M (+2.65 %)
Sep 27 2019	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Sell	S	28.25	20,000	565,000	2,121,903	2.1 M to 2.1 M (-0.93 %)
Sep 27 2019	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Sell	S	28.25	20,000	565,000	2,121,903	2.1 M to 2.1 M (-0.93 %)
Sep 24 2019	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Option Exercise	M	5.10	66,645	339,890	1,001,868
Sep 24 2019	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Option Exercise	M	5.10	41,755	212,951	1,068,513
Sep 24 2019	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Option Exercise	M	5.10	66,645	339,890	1,001,868
Sep 24 2019	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Option Exercise	M	5.10	4,250	21,675	1,110,268
Sep 24 2019	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Option Exercise	M	5.10	41,755	212,951	1,068,513
Sep 24 2019	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Sell	S	29.04	12,673	368,024	2,141,903	2.2 M to 2.1 M (-0.59 %)
Sep 24 2019	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Option Exercise	M	5.10	4,250	21,675	1,110,268
Sep 24 2019	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Sell	S	28.00	53,972	1,511,216	2,154,576	2.2 M to 2.2 M (-2.44 %)
Sep 24 2019	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Sell	S	29.04	12,673	368,024	2,141,903	2.2 M to 2.1 M (-0.59 %)
Sep 24 2019	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Buy	M	5.10	66,645	339,890	2,208,548	2.1 M to 2.2 M (+3.11 %)
Sep 24 2019	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Sell	S	28.00	53,972	1,511,216	2,154,576	2.2 M to 2.2 M (-2.44 %)
Sep 24 2019	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Sell	S	29.04	41,755	1,212,565	2,141,903	2.2 M to 2.1 M (-1.91 %)
Sep 24 2019	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Buy	M	5.10	66,645	339,890	2,208,548	2.1 M to 2.2 M (+3.11 %)
Sep 24 2019	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Buy	M	5.10	41,755	212,951	2,183,658	2.1 M to 2.2 M (+1.95 %)
Sep 24 2019	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Sell	S	29.04	41,755	1,212,565	2,141,903	2.2 M to 2.1 M (-1.91 %)
Sep 24 2019	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Sell	S	29.00	4,250	123,250	2,141,903	2.1 M to 2.1 M (-0.20 %)
Sep 24 2019	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Buy	M	5.10	41,755	212,951	2,183,658	2.1 M to 2.2 M (+1.95 %)
Sep 24 2019	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Buy	M	5.10	4,250	21,675	2,146,153	2.1 M to 2.1 M (+0.20 %)
Sep 24 2019	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Sell	S	29.00	4,250	123,250	2,141,903	2.1 M to 2.1 M (-0.20 %)
Sep 24 2019	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Buy	M	5.10	4,250	21,675	2,146,153	2.1 M to 2.1 M (+0.20 %)
May 29 2019	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Option Exercise	M	2.62	9,376	24,565	1,133,418
May 29 2019	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Option Exercise	M	2.01	40,072	80,545	1,142,794
May 29 2019	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Buy	M	2.62	9,376	24,565	2,141,903	2.1 M to 2.1 M (+0.44 %)
May 29 2019	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Buy	M	2.01	40,072	80,545	2,132,527	2.1 M to 2.1 M (+1.92 %)
Apr 05 2019	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Sell	S	19.30	50,000	965,000	2,092,455	2.1 M to 2.1 M (-2.33 %)
Jan 03 2019	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Grant	A	0.00	600,000	0	2,142,455	1.5 M to 2.1 M (+38.90 %)
Dec 21 2018	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Sell	S	13.92	90,000	1,252,800	1,542,455	1.6 M to 1.5 M (-5.51 %)
Dec 14 2018	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Sell	S	14.07	90,000	1,266,300	1,632,455	1.7 M to 1.6 M (-5.23 %)
Nov 09 2018	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Sell	S	14.95	5,300	79,235	1,722,455	1.7 M to 1.7 M (-0.31 %)
Nov 09 2018	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Sell	S	14.35	76,200	1,093,470	1,727,755	1.8 M to 1.7 M (-4.22 %)
Sep 05 2018	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Sell	S	14.45	64,834	936,851	1,803,955	1.9 M to 1.8 M (-3.47 %)
Sep 05 2018	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Sell	S	14.45	100,000	1,445,000	1,868,789	2 M to 1.9 M (-5.08 %)
Mar 16 2018	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Sell	S	7.40	26,000	192,400	1,968,789	2 M to 2 M (-1.30 %)
Mar 15 2018	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Sell	S	7.41	100,000	741,000	1,994,789	2.1 M to 2 M (-4.77 %)
Mar 15 2018	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Sell	S	7.44	100,000	744,000	2,094,789	2.2 M to 2.1 M (-4.56 %)
Mar 15 2018	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Sell	S	7.43	100,000	743,000	2,194,789	2.3 M to 2.2 M (-4.36 %)
Jan 03 2018	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Grant	A	0.00	500,000	0	2,294,789	1.8 M to 2.3 M (+27.86 %)
Apr 14 2017	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Grant	A	0.00	978,000	0	1,794,789	816.8 K to 1.8 M (+119.74 %)
Dec 15 2016	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Payment of Exercise	F	1.27	300,444	381,564	816,789	1.1 M to 816.8 K (-26.89 %)
Jul 05 2016	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Option Exercise	X	5.09	15,772	80,279	0
Jul 05 2016	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Buy	M	5.09	15,772	80,279	1,117,233	1.1 M to 1.1 M (+1.43 %)
Jan 04 2016	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Option Exercise	A	6.15	80,000	492,000	1,166,466
Jan 04 2016	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Grant	A	0.00	540,000	0	1,101,461	561.5 K to 1.1 M (+96.18 %)
Jan 04 2016	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Payment of Exercise	F	6.13	58,712	359,905	561,461	620.2 K to 561.5 K (-9.47 %)
Mar 06 2015	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	President and CEO	Option Exercise	A	7.75	300,000	2,325,000	1,086,466
Mar 06 2015	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	President and CEO	Grant	A	0.00	360,000	0	620,173	260.2 K to 620.2 K (+138.37 %)
Aug 31 2010	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	President and CEO	Buy	P	0.89	10,000	8,900	341,729	331.7 K to 341.7 K (+3.01 %)
Aug 30 2010	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	President and CEO	Buy	P	0.89	10,000	8,900	331,729	321.7 K to 331.7 K (+3.11 %)
Aug 17 2010	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	President and CEO	Option Exercise	A	0.99	500,000	495,000	2,214,750
Mar 08 2010	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	President and CEO	Option Exercise	A	0.52	563,250	292,890	1,714,750
Oct 13 2009	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	President and CEO	Option Exercise	A	0.51	1,126,500	574,515	1,151,500
Aug 19 2009	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	President and CEO	Option Exercise	J	3.92	2,000,000	7,840,000	25,000
Jan 23 2009	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	President and CEO	Option Exercise	A	2.13	25,000	53,250	2,025,000
Aug 25 2008	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	President and CEO	Option Exercise	P	2.00	164,000	328,000	164,000
Aug 25 2008	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	President and CEO	Buy	P	0.00	164,000	0	164,000	0 to 164 K

Page: 1